AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Paboriv EL 75mg/40mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Remandish Pharma Pvt Ltd

Salt Composition

Levosulpiride (75mg) + Esomeprazole (40mg)

Overview Paboriv EL 75mg/40mg Tablet SR

Gastroesophageal reflux disease (GERD, or acid reflux) can be managed with the prescription medication, Paboriv EL 75mg/40mg Extended-Release Tablets. This medication targets GERD symptoms like heartburn, abdominal pain, and irritation by reducing stomach acid production. Paboriv EL should be taken on an empty stomach, following your doctor's prescribed dosage and duration. Treatment length depends on individual response and condition severity; premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your physician of all other medications you are using, as interactions are possible. Common side effects, often transient, include diarrhea, nausea, vomiting, abdominal pain, gas, constipation, and headache. Report any concerning side effects immediately to your doctor. Constipation can be mitigated by increasing dietary fiber and fluid intake. Drowsiness is a potential side effect; avoid driving or activities requiring alertness until its impact is known. Alcohol consumption should be avoided due to potential drowsiness exacerbation. Lifestyle adjustments—such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate—may enhance treatment effectiveness. If pregnant, planning pregnancy, breastfeeding, or have liver or kidney disease, consult your doctor before starting Paboriv EL to ensure appropriate dosage.

Primary Ingredients of Paboriv EL 75mg/40mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Paboriv EL 75mg/40mg Tablet SR

Managing gastroesophageal reflux disease (GERD)

Major Benefits of Paboriv EL 75mg/40mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Paboriv EL 75mg/40mg Tablet SR on an empty stomach.

Common Side effects of Paboriv EL 75mg/40mg Tablet SR:

  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Upset stomach
  • Stomach pain
  • Headache
  • Flatulence
  • Sleepiness
  • Fundic gland polyps

How to use Paboriv EL 75mg/40mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; do not chew, crush, or fracture it. Consume Paboriv EL 75mg/40mg Tablet SR on an empty stomach.

How Paboriv EL 75mg/40mg Tablet SR works:

Each Paboriv EL 75mg/40mg sustained-release tablet contains levosulpiride and esomeprazole, two active pharmaceutical ingredients.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Paboriv EL 75mg/40mg Tablet SR is not advised due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Paboriv EL 75mg/40mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Paboriv EL 75mg/40mg sustained-release tablets with breastfeeding are currently lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Driving ability may be impaired by Paboriv EL 75mg/40mg Tablet SR, which can induce drowsiness, numbness, or dyskinesias. Consequently, patients should refrain from driving and other activities demanding close attention.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Paboriv EL 75mg/40mg extended-release tablets in individuals with renal impairment. Physician consultation is recommended. Available evidence, however, suggests a need for prudence when prescribing this medication to such patients.

LiverLiverCAUTION

Patients with severe hepatic impairment should exercise caution when using Paboriv EL 75mg/40mg sustained-release tablets. Dosage modification of Paboriv EL 75mg/40mg sustained-release tablets may be necessary. Physician consultation is advised.

What if you forget to take Paboriv EL 75mg/40mg Tablet SR :

Should you forget a Paboriv EL 75mg/40mg Tablet SR dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Paboriv EL 75mg/40mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Gastrointestinal system

FAQs on Paboriv EL 75mg/40mg Tablet SR

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Always follow your doctor's instructions when taking Paboriv EL 75mg/40mg SR tablets. One tablet daily, taken on an empty stomach, is usually recommended.
Patients allergic to any ingredient or inactive substance in Paboriv EL 75mg/40mg SR Tablets should not use this medication.
Dizziness, including faintness, weakness, unsteadiness, or lightheadedness, is a possible side effect of Paboriv EL 75mg/40mg Tablet SR. If you experience dizziness, rest until symptoms subside before resuming activities.
Studies in adults suggest a link between Paboriv EL 75mg/40mg Tablet SR treatment and a higher risk of hip, wrist, or spine fractures related to osteoporosis. This increased fracture risk is observed particularly in patients receiving high doses, defined as multiple daily doses or long-term use (one year or more).
Paboriv EL 75mg/40mg Tabl...
202